E. Bakhshi, M. Eshraghian, K. Mohammad, and B. Seifi. BMC medical research methodology, (January 2008)5162<m:linebreak></m:linebreak>JID: 100968545; OID: NLM: PMC2613917; 2008/07/06 received; 2008/11/25 accepted; 2008/11/25 aheadofprint; epublish;.
M. Bobbio, B. Demichelis, and G. Giustetto. Lancet, 343 (8907):
1209-11(May 1994)6680<m:linebreak></m:linebreak>LR: 20071115; JID: 2985213R; OID: KIE: 43813; OTO: KIE; GN: KIE: KIE BoB Subject Heading: human experimentation/research design; GN: KIE: KIE BoB Subject Heading: patient care/drugs; GN: KIE: Full author name: Bobbio, Marco; GN: KIE: Full author name: Demichelis, Brunella; GN: KIE: Full author name: Giustetto, Guido; ppublish;<m:linebreak></m:linebreak>Presentació de dades.
P. Burton, A. Hansell, I. Fortier, T. Manolio, M. Khoury, J. Little, and P. Elliott. International journal of epidemiology, 38 (1):
263-73(February 2009)4935<m:linebreak></m:linebreak>GR: 075883/Wellcome Trust/United Kingdom; GR: G9806740/Medical Research Council/United Kingdom; JID: 7802871; CIN: Int J Epidemiol. 2009 Feb;38(1):274-5. PMID: 18984600; OID: NLM: PMC2639365; 2008/08/01 aheadofprint; 2008/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Epidemiologia genètica.
J. Calvo-Gómez, R. Sánchez-Pedraza, L. Jaramillo-González, and C. Tarcisio-Mantilla. Revista de salud pública (Bogotá, Colombia), 8 (1):
74-87(2006)5444<m:linebreak></m:linebreak>LR: 20061115; JID: 100936348; 0 (Antipsychotic Agents); ppublish;<m:linebreak></m:linebreak>Validació d'escales.
T. Cleophas, A. Zwinderman, and B. van Ouwerkerk. American journal of therapeutics, 19 (1):
e1-7(January 2012)21048432<br/><br/>JID: 9441347; ppublish;<br/><br/>Mixed models; Dades longitudinals; SPSS.
F. de Vries, C. de Vries, C. Cooper, B. Leufkens, and T. van Staa. International journal of epidemiology, 35 (5):
1301-8(October 2006)4268<m:linebreak></m:linebreak>PUBM: Print; JID: 7802871; 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); CIN: Int J Epidemiol. 2006 Oct;35(5):1308-9. PMID: 17053012; CIN: Int J Epidemiol. 2006 Oct;35(5):1310-1. PMID: 17053013; CIN: Int J Epidemiol. 2006 Oct;35(5):1312-3. PMID: 17053014; ppublish;<m:linebreak></m:linebreak>New-user designs; Mesures d'associació.
J. Delaney, S. Daskalopoulou, and S. Suissa. Pharmacoepidemiology and drug safety, 18 (1):
1-6(January 2009)5076<m:linebreak></m:linebreak>JID: 9208369; 0 (Adrenergic beta-Antagonists); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Marginal structural models; Exemple.
J. Donzé, D. Aujesky, D. Williams, and J. Schnipper. JAMA internal medicine, 173 (8):
632-8(April 2013)7278<br/>JID: 101589534; aheadofprint; SO: JAMA Intern Med. 2013 Mar 25:1-7. doi: 10.1001/jamainternmed.2013.3023.;<br/>Models predictius; Proves diagnòstiques.
S. Fieuws, and G. Verbeke. Statistics in medicine, 23 (20):
3093-104(October 2004)4302<m:linebreak></m:linebreak>PUBM: Print; CI: Copyright 2004; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Mixed models.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
B. Galobardes, M. Shaw, D. Lawlor, J. Lynch, and G. Smith. Journal of epidemiology and community health, 60 (2):
95-101(February 2006)4308<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print; JID: 7909766; ppublish;<m:linebreak></m:linebreak>Farmacoeconomia.
H. Gardarsdottir, E. Heerdink, and A. Egberts. Pharmacoepidemiology and drug safety, 15 (5):
338-43(May 2006)4368<br/>PUBM: Print; JID: 9208369; 0 (Antidepressive Agents); ppublish;<br/>Mesures de freqüència.
O. Hägg, P. Fritzell, and A. Nordwall. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 12 (1):
12-20(February 2003)4456<m:linebreak></m:linebreak>LR: 20061115; PUBM: Print-Electronic; JID: 9301980; CIN: Eur Spine J. 2003 Feb;12(1):21. PMID: 15612120; 2002/02/08 received; 2002/06/01 revised; 2002/06/07 accepted; 2002/10/24 aheadofprint; ppublish;<m:linebreak></m:linebreak>MDCI.
N. Ikeda, M. Inoue, H. Iso, S. Ikeda, T. Satoh, M. Noda, T. Mizoue, H. Imano, E. Saito, K. Katanoda and 5 other author(s). PLoS medicine, 9 (1):
e1001160(January 2012)6526<m:linebreak></m:linebreak>JID: 101231360; OID: NLM: PMC3265534; 2011/07/28 received; 2011/12/06 accepted; 2012/01/24 epublish; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
T. Itatsu, A. Nagahara, M. Hojo, A. Miyazaki, T. Murai, M. Nakajima, and S. Watanabe. Internal medicine (Tokyo, Japan), 50 (7):
713-7(January 2011)JID: 9204241; 0 (Serotonin Uptake Inhibitors); 2011/04/01 epublish; ppublish; Confusió absoluta entre cas-control i exposats-no exposats<br/><br/><br/>Tipus d'estudis.
K. Janssen, K. Moons, C. Kalkman, D. Grobbee, and Y. Vergouwe. Journal of clinical epidemiology, 61 (1):
76-86(January 2008)4731<br/>JID: 8801383; 2006/08/22 received; 2007/03/08 revised; 2007/04/20 accepted; 2007/11/26 aheadofprint; ppublish;<br/>Models predictius; Avaluació de riscs.
G. Kalton, and A. Piesse. Statistics in medicine, 26 (8):
1675-87(April 2007)4668<m:linebreak></m:linebreak>LR: 20071115; CI: c 2007; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Tipus d'estudis.
H. Kim. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (2 Pt 1):
559-65(January 2007)4698<m:linebreak></m:linebreak>LR: 20071203; GR: AI 029530/AI/NIAID NIH HHS/United States; GR: HL 070149/HL/NHLBI NIH HHS/United States; JID: 9502500; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.
D. Lai, T. King, L. Moyé, and Q. Wei. Annals of epidemiology, 13 (3):
204-8(March 2003)3153<m:linebreak></m:linebreak>Sample size; Surrogate endpoints; Dades longitudinals.